[Pao Feng Biotechnology] May 2026 Revenue Reaches NT$234 Million (YoY +1.8%)
Pao Feng Biotechnology (1760) announced its revenue for May 2026, reaching NT$234 million (234,475 thousand NTD), representing a modest year-on-year increase of 1.8%.
📋 Article Processing Timeline
- 📰 Published: May 1, 2026 at 09:00
- 🔍 Collected: June 12, 2026 at 08:00 (1007h 0m after Published)
- 🤖 AI Analyzed: June 12, 2026 at 16:44 (8h 44m after Collected)
Company Code: 1760
Company Name: Pao Feng Biotechnology
Industry: Biotechnology and Medical Care
Data Period: 2026-05
Monthly Revenue: 234,475 thousand NTD (234 million NTD)
Year-on-Year Change: +1.8%
Keywords: Monthly Revenue, Biotechnology and Medical Care
Company Name: Pao Feng Biotechnology
Industry: Biotechnology and Medical Care
Data Period: 2026-05
Monthly Revenue: 234,475 thousand NTD (234 million NTD)
Year-on-Year Change: +1.8%
Keywords: Monthly Revenue, Biotechnology and Medical Care
FAQ
What is Pao Feng Biotechnology's revenue for May 2026?
The monthly revenue is NT$234,475 thousand (approximately NT$234 million).
How did the revenue change compared to last year?
It increased by 1.8% compared to the same month last year.
What is the company code and industry of Pao Feng?
The company code is 1760, and the industry is Biotechnology and Medical Care.